Jonathan E. Campbell

Endocrinology, Diabetes and Metabolism · 2001–2013

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom Jonathan E. Campbell trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Hill
  2. D. J. Drucker
  3. Mark A. Davis

Who trusts Jonathan E. Campbell overall

  1. D. J. Drucker
  2. F. Marra

Papers from Jonathan E. Campbell's perspective

Ordered by how strongly the researchers Jonathan E. Campbell trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes (Nature Genetics)
  2. Inhibition of gastric inhibitory polypeptide signaling prevents obesity (Nature Medicine)
  3. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. (Journal of Clinical Investigation)
  4. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection (Nature Medicine)
  5. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. (Current Medical Research and Opinion)
  6. Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. (Endocrinology)
  7. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge (Nature Genetics)
  8. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells (Nature Medicine)
  9. Fluctuating resources in plant communities: a general theory of invasibility
  10. The biology of incretin hormones. (Cell Metabolism)

Their papers